Morningside Ventures

• Mighty Therapeutics

• Cognito Therapeutics

  Series C, Lead, Mar 6, 2026

• AdvanCell

  Series C, Feb 13, 2025

• AdvanCell

  Series C, Feb 3, 2025

• Alentis Therapeutics

  Series D, Nov 12, 2024

• MedRhythms

  Series B, Lead, Jul 28, 2021

• Amylyx Pharmaceuticals

  Series C-1, $10M, Jul 1, 2021

• Atea Pharmaceuticals

  Series D-1, Oct 1, 2020

• Amylyx Pharmaceuticals

  Series B, $5M, Jun 1, 2020

• Atea Pharmaceuticals

  Series D, May 1, 2020

• Elysium Health

  Series C, Dec 23, 2019

Sources: mightytx.com, news.google.com, startupdaily.net, fiercebiotech.com, businesswire.com, sec.gov, finsmes.com